IL1B and inflammatory bowel disease: Although these cytokines are considered key pro-inflammatory mediators in IBD, our findings align with other studies using TNBS or DNBS models, in which systemic levels of TNF-α and IL-1β often remain unchanged despite evident local inflammation [51,52].